13F filing recap · Q2 2021
What did ValueAct Capital buy in Q2 2021?
Reported stock-position changes between this filing and the previous one.
Stock value
$9.02B
Positions
13
Estimated turnover
55.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.